You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

docetaxel

Showing 26 - 50 of 1,353
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)

Not yet recruiting
  • Breast Cancer
  • Shenyang, Liaoning, China
    Shengjing Hospital of China Medical University
Dec 2, 2022

Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)

Recruiting
  • Gastric Cancer
  • +10 more
  • Docetaxel
  • +3 more
  • Kyiv, Ukraine
    National Cancer Institute
Aug 31, 2023

HER2-positive Breast Cancer Trial in Shanghai (SYSA1901, Pertuzumab, Trastuzumab)

Recruiting
  • HER2-positive Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 8, 2023

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (utidelone, docetaxel)

Not yet recruiting
  • Breast Neoplasms
  • Locally Advanced or Metastatic Breast Cancer
  • Guangzhou, Gangdong, China
    Shusen Wang
Jun 21, 2022

HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)

Recruiting
  • HER2 Positive Early Breast Cancer
  • Docetaxel
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023

Head and Neck Squamous Carcinoma Trial in Shanghai (SCT-I10A, SCT200, paclitaxel)

Recruiting
  • Head and Neck Squamous Carcinoma
  • Shanghai, China
    Shanghai East Hospital
Sep 22, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Docetaxel
  • +6 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)

Recruiting
  • Breast Cancer
  • Docetaxel
  • +6 more
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022

Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Sep 9, 2022

Prostate Cancer Trial in United States (DKN-01 300 mg, DKN-01 600 mg, Docetaxel 75 mg/m2)

Terminated
  • Prostate Cancer
  • San Francisco, California
  • +4 more
Jan 30, 2023

Non Small Cell Lung Cancer, NSCLC, Small-cell Lung Cancer Trial in Saint Louis (ADI-PEG 20, Gemcitabine, Docetaxel)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • ADI-PEG 20
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 14, 2022

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD6094, docetaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Seoul, Korea, Republic Of, Korea, Republic of
    Samsung Medical Center
Jun 13, 2022

Prostate Cancer Trial in United States (Apalutamide, Androgen deprivation, Salvage radiation therapy)

Active, not recruiting
  • Prostate Cancer
  • Omaha, Nebraska
  • +4 more
Nov 10, 2022

Head and Neck Squamous Cell Carcinoma Trial in Norfolk, Omaha (Capecitabine, Docetaxel, Quality-of-Life Assessment)

Terminated
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • Norfolk, Nebraska
  • +2 more
Aug 10, 2022

Lung Cancer Trial in Cleveland, Mayfield Heights (bevacizumab, docetaxel, gemcitabine HCl)

Completed
Has Results
  • Lung Cancer
  • bevacizumab
  • +2 more
  • Cleveland, Ohio
  • +3 more
Jul 22, 2022

First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer Trial (KN026, HB1801, Pertuzumab)

Not yet recruiting
  • First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
  • (no location specified)
Apr 20, 2023

Breast Cancer, Chemo Effect Trial (Nab paclitaxel, Docetaxel)

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Nab paclitaxel
  • Docetaxel
  • (no location specified)
Feb 11, 2022

Metastatic Hormone Naive Prostate Cancer Trial in Australia (177Lu-PSMA-617, Docetaxel)

Recruiting
  • Metastatic Hormone Naive Prostate Cancer
  • Sydney, New South Wales, Australia
  • +4 more
Nov 4, 2022

Breast Cancer Trial in Cincinnati, Houston (Docetaxel, Carboplatin)

Active, not recruiting
Has Results
  • Breast Cancer
  • Cincinnati, Ohio
  • +2 more
Apr 6, 2022

Effect of Drug Trial in Sapporo (Docetaxel, Pembrolizumab)

Not yet recruiting
  • Effect of Drug
  • Sapporo, Hokkaido, Japan
    Hokkaido University Hospital
Feb 12, 2022

Prostate Cancer Trial in Philadelphia (docetaxel, sorafenib tosylate)

Completed
Has Results
  • Prostate Cancer
  • docetaxel
  • sorafenib tosylate
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Feb 16, 2022

Triple Negative Breast Cancer, Anthracycline-refractory TNBC Trial in Houston (Docetaxel, Pembrolizumab, IL-12 gene therapy)

Suspended
  • Triple Negative Breast Cancer
  • Anthracycline-refractory TNBC
  • Docetaxel
  • +2 more
  • Houston, Texas
    Houston Methodist Cancer Center
Mar 28, 2022